genetics

STAT covers a wide range of topics related to genetics, including the latest research, ethical issues, and policy implications. This page features in-depth reporting and analysis from STAT News’ team of science journalistsand it is a valuable resource for anyone interested in this rapidly evolving field.

Articles below include the development of new gene-editing technologies, the discovery of new genes associated with diseases, the use of genetics to personalize medicine and the regulation of genome editing.

All Coverage

Politics John Wilkerson

Most Read

Study: Rare genetic mutation appears to have protected second person from early Alzheimer’s

STAT Plus: Tracking the FDA advisory panel on Sarepta’s gene therapy for Duchenne muscular dystrophy

STAT Plus: Gene therapy death not caused by CRISPR, investigators confirm

23andMe had devastating news about my health. I wish a person had delivered it

STAT Plus: Early findings in gene therapy death suggest CRISPR was not the cause

Human reproductive cloning: The curious incident of the dog in the night-time

Revenge of the gaslit patients: Now, as scientists, they’re tackling Ehlers-Danlos syndromes

STAT Plus: A bellwether moment: Once a distant dream, gene therapy for Duchenne nears historic decision

All Coverage

STAT Plus: FDA official offers insights into whether gene therapy makers could use common manufacturing process

Listen: Pharma vs. PBMs, Sarepta at the FDA, & a bold idea gone awry

Human ‘pangenome’ published, with goal of making genomics more useful for diverse populations

STAT Plus: What to know about a pivotal FDA hearing on Sarepta’s gene therapy for Duchenne

Rare-disease doctors support expanded newborn genomic screening, survey finds

STAT Plus: Doudna talks cost, access issues looming over first CRISPR therapy

STAT Plus: Gene therapy has helped boys like Conner walk. Scientists are trying to keep it that way

Vast sequencing project begins to unlock human genome’s secrets — by deciphering other mammals’ DNA

STAT Plus: Where are the guidelines for the production of animals with intentional genomic alterations?

STAT Plus: FDA staff leaned toward rejecting Sarepta gene therapy before top official intervened

Large European study underlines power of genomic sequencing to diagnose diseases

Why genetic testing should always be offered to children with neurodevelopmental differences

In a world of synthetic biology, publishing virus DNA sequences may mean perishing

STAT Plus: A young boy’s nightmare diagnosis, and the $3 million one-time treatment that will likely save his life

STAT Plus: A devastating skin condition could soon get its first medication, as the frontiers of gene therapy expand

Genetic differences in breast tumors may contribute to racial disparities

STAT Plus: New research may give geneticists a long-sought tool: a targeted protein delivery device

Why the rise of DNA testing is creating challenges — and an opportunity

STAT Plus: Researchers devise new strategies to overcome a key CRISPR flaw

Stanford scientist who broke genome sequencing record on what faster diagnoses mean for patients

STAT Plus: Top FDA official: Agency needs to start using accelerated approval for gene therapies

National Academies calls for transforming use of racial and ethnic labels in genetics research

Setting aside the thorniest issues around CRISPR babies, scientists say embryo-editing research should proceed

STAT Plus: Illumina has been ignoring its investors, but it can’t ignore Carl Icahn

STAT Plus: FDA approves first treatment for Rett syndrome, a genetic neurological disease

You've been selected! STAT+ for less than $2/day

Subscribe to STAT+ for less than $2 per day

Subscribe to STAT+ for less than $2 per day

Become a STAT+ subscriber today!